Oxford Biomedica plans to raise £16 mln to develop eye disease products
05:01 EDT 29 Jun 2012 | Proactive Investors
Oxford Biomedica (LON:OXB) revealed plans today to raise £16 million through the issue of new shares, so it can develop its gene delivery technology, with a focus on its eye-disease focused products. It is intended that the biopharmaceutical &n..
Original Article: Oxford Biomedica plans to raise £16 mln to develop eye disease products
More From BioPortfolio on "Oxford Biomedica plans to raise £16 mln to develop eye disease products"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
